X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (447) 447
Book Review (46) 46
Publication (35) 35
Conference Proceeding (28) 28
Book / eBook (10) 10
Newspaper Article (10) 10
Book Chapter (6) 6
Web Resource (2) 2
Magazine Article (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (281) 281
humans (268) 268
gastroenterology & hepatology (201) 201
male (186) 186
female (185) 185
middle aged (163) 163
adult (151) 151
hepatitis c, chronic - drug therapy (112) 112
antiviral agents - therapeutic use (104) 104
drug therapy, combination (83) 83
hepatitis c (82) 82
hepacivirus - genetics (77) 77
interferon-alpha - therapeutic use (74) 74
recombinant proteins (74) 74
treatment outcome (71) 71
aged (68) 68
ribavirin - therapeutic use (67) 67
abridged index medicus (65) 65
interferon (63) 63
ribavirin (62) 62
gastroenterology and hepatology (58) 58
genotype (58) 58
polyethylene glycols - therapeutic use (54) 54
cirrhosis (53) 53
hepatitis (49) 49
virus-infection (49) 49
plus ribavirin (48) 48
hepatitis c virus (45) 45
therapy (44) 44
antiviral agents - adverse effects (42) 42
antiviral agents - administration & dosage (40) 40
care and treatment (40) 40
rna, viral - blood (40) 40
surgery (39) 39
hepatitis c, chronic - virology (38) 38
transplantation (38) 38
fibrosis (36) 36
liver - pathology (36) 36
prospective studies (36) 36
health aspects (34) 34
risk factors (34) 34
adolescent (33) 33
drug therapy (33) 33
retrospective studies (33) 33
interferon-alpha - administration & dosage (32) 32
alanine transaminase - blood (31) 31
chronic hepatitis-c (31) 31
infection (31) 31
liver (31) 31
ribavirin - administration & dosage (31) 31
combination therapy (30) 30
double-blind method (30) 30
liver transplantation (30) 30
ribavirin - adverse effects (30) 30
article (29) 29
biopsy (29) 29
peginterferon alpha-2a (29) 29
hepacivirus - drug effects (28) 28
liver diseases (28) 28
medicine, general & internal (28) 28
recurrence (28) 28
united-states (28) 28
initial treatment (27) 27
interferon-alpha - adverse effects (27) 27
viral load (27) 27
time factors (26) 26
drug administration schedule (25) 25
hepatitis c, chronic - complications (25) 25
natural-history (25) 25
disease progression (24) 24
hepacivirus - isolation & purification (23) 23
patients (23) 23
young adult (23) 23
clinical trials (22) 22
dose-response relationship, drug (22) 22
follow-up studies (22) 22
hepatology (22) 22
medicine & public health (22) 22
prevalence (22) 22
antiviral agents (21) 21
combination (21) 21
hepatitis c - drug therapy (21) 21
hepatitis c, chronic - pathology (21) 21
liver cirrhosis - virology (21) 21
liver cirrhosis (20) 20
analysis (19) 19
genotype & phenotype (19) 19
liver cirrhosis - pathology (19) 19
peginterferon (19) 19
pharmacology & pharmacy (19) 19
polyethylene glycols - administration & dosage (19) 19
recombinant proteins - therapeutic use (19) 19
trial (19) 19
liver cirrhosis - complications (18) 18
management (18) 18
polyethylene glycols - adverse effects (18) 18
rna (18) 18
disease (17) 17
hepatitis c, chronic - blood (17) 17
infections (17) 17
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Online Resources - Online (1) 1
Robarts - Reference (1) 1
St. Michael's College (John M. Kelly) - Reference (1) 1
St. Michael's Hospital - Online (1) 1
Trinity College (John W Graham) - Reference (1) 1
Trinity College (John W Graham) - Storage (1) 1
UTL at Downsview - May be requested (1) 1
UofT at Scarborough - Stacks (1) 1
Victoria University E.J. Pratt - Reference (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Gastroenterology, ISSN 0016-5085, 01/2018, Volume 154, Issue 1, pp. 253 - 254
Journal Article
Gastroenterology, ISSN 0016-5085, 01/2018, Volume 154, Issue 1, pp. 253 - 254
Journal Article
2004, 1st ed., ISBN 9780444513441, xv, 603
Book
Gastroenterology, ISSN 0016-5085, 2014, Volume 146, Issue 2, pp. 583 - 584
Journal Article
American Journal of Gastroenterology, ISSN 0002-9270, 08/2018, Volume 113, Issue 8, pp. 1251 - 1252
Journal Article
Hepatology, ISSN 0270-9139, 06/2019, Volume 69, Issue 6, pp. 2664 - 2671
Journal Article
2008, Curbside consultation in gastroenterology
Web Resource
American Journal of Gastroenterology, ISSN 0002-9270, 2018, Volume 114, Issue 1, pp. 48 - 63
Primary biliary cholangitis (PBC) is a chronic, cholestatic, autoimmune disease with a variable progressive course. PBC can cause debilitating symptoms... 
ANTIMITOCHONDRIAL ANTIBODIES | CONTROLLED-TRIAL | HEPATOCELLULAR-CARCINOMA | RISK-FACTORS | LIVER-TRANSPLANTATION | URSODEOXYCHOLIC ACID | SOLUBLE VITAMIN LEVELS | BIOCHEMICAL RESPONSE | CLINICAL-FEATURES | GASTROENTEROLOGY & HEPATOLOGY | PYRUVATE-DEHYDROGENASE COMPLEX
Journal Article
Gastroenterology, ISSN 0016-5085, 2012, Volume 143, Issue 1, pp. 267 - 268
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2014, Volume 370, Issue 21, pp. 1973 - 1982
In patients with HCV genotype 1 infection and cirrhosis, the rate of sustained virologic response was 92% with three new antiviral agents plus ribavirin for 12... 
SUSTAINED VIROLOGICAL RESPONSE | ALL-CAUSE MORTALITY | UNITED-STATES | MEDICINE, GENERAL & INTERNAL | VIRUS-INFECTION | TELAPREVIR | THERAPY | GENOTYPE 1 INFECTION | BOCEPREVIR | HCV INFECTION | EPIDEMIOLOGY | Recurrence | Anilides - therapeutic use | Anilides - adverse effects | Humans | Middle Aged | Drug Resistance, Viral | Hepacivirus - genetics | Male | Hepatitis C, Chronic - complications | Adult | Female | Drug Therapy, Combination | Hepacivirus - isolation & purification | Liver Cirrhosis - drug therapy | Liver Cirrhosis - etiology | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Genotype | Logistic Models | Macrocyclic Compounds - adverse effects | Hepatitis C, Chronic - drug therapy | Macrocyclic Compounds - therapeutic use | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Carbamates - adverse effects | Aged | Carbamates - therapeutic use | Complications and side effects | Evaluation | Care and treatment | Usage | Hepatitis C | Liver cirrhosis | Ribavirin | Headache | Antiviral agents | Ritonavir | Body weight | Fatigue | Infections | Nausea | Proteinase inhibitors | RNA polymerase | Patients | Cirrhosis | Liver cancer | Genotype & phenotype | Hepatitis | Hemoglobin | Interferon | Drug therapy | Genotypes | Index Medicus | Abridged Index Medicus | Cirrosi hepàtica | Inhibidors enzimàtics | Enzyme inhibitors | Hepatic cirrhosis
Journal Article
Hepatology, ISSN 0270-9139, 09/2010, Volume 52, Issue 3, pp. 833 - 844
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2009, Volume 361, Issue 6, pp. 580 - 593
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2015, Volume 373, Issue 27, pp. 2608 - 2617
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 05/2014, Volume 370, Issue 20, pp. 1879 - 1888
Journal Article